Filovirus Consensus Antigens, Nucleic Acid Constructs And Vaccines Made Therefrom, And Methods Of Using Same
AssigneeThe Trustees of the University of Pennsylvania
InventorsDavid B. Weiner, Devon Shedlock
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of the University of Pennsylvania
InventorsDavid B. Weiner, Devon Shedlock
Estimating the term…
Nucleic acid molecules and compositions comprising one or more nucleic acid sequences that encode a consensus filovirus immunogen including a consensus Marburgvirus filovirus glycoprotein MARV GP immunogen, a consensus Ebolavirus Sudan filovirus glycoprotein SEBOV GP immunogen and a consensus Ebolavirus Zaire glycoprotein ZEBOV GP immunogen are disclosed. The coding sequences optionally include operable linked coding sequence that encode a signal peptide. Immunomodulatory methods and methods of inducing an immune response against filovirus, particularly Marburgvirus, Ebolavirus Sudan and Ebolavirus Zaire are disclosed. Method of preventing filovirus infection, particularly infection by Marburgvirus, Ebolavirus Sudan and Ebolavirus Zaire and methods of treating individuals infected with filovirus infection, particularly infection by Marburgvirus, Ebolavirus Sudan and Ebolavirus Zaire are disclosed. Consensus filovirus proteins are disclosed.
-41. (canceled)
A nucleic acid molecule comprising a nucleotide sequence encoding a consensus Filoviridae envelope glycoprotein immunogen, wherein the nucleotide sequence is selected from the group consisting of:
A nucleic acid molecule comprising a nucleotide sequence encoding a Filoviridae envelope glycoprotein immunogen, wherein the nucleotide sequence encodes a Marburg marburgvirus envelope glycoprotein immunogen, wherein the amino acid sequence of the Marburg marburgvirus envelope glycoprotein immunogen is selected from the group consisting of:
Dependencies are inferred from the claim text.